52 weeks low stocks that are high ROCE and low debt . Time to invest in these stocks when Nifty is at its lifetime high.
Indoco Remedies Ltd.
Indoco Remedies Ltd. known through its brands such as Homide, Renolen, Dexoren, Mofloren – BF, Mofloren LP, Mofloren – D, Clygan, Sensochek, Zincoren, Tobaren – DM, Irisol Plus, and Blu Dye. Indoco Remedies stands as a leading manufacturer of Active Pharmaceutical Ingredients (APIs) catering to a wide spectrum of therapeutic categories, ranging from antibiotics, anti-inflammatory, anti-diabetic, cardiovascular, to central nervous system drugs.
Indoco Remedies has received the prestigious EU GMP (European Union Good Manufacturing Practice) certification for its API manufacturing facility in Baddi, Himachal Pradesh. It can now export its APIs to the European Union market, opening up new avenues for growth and expansion.
With acquisition of 85% stake in US-based FFP Holding, Indoco Remedies can now expand its presence in the US OTC (over the counter)market.
Indoco Remedies is trading at a strong support of 312 and can be kept till lifetime high of Rs. 530 for 65% return.
Rajesh Exports Ltd.
Rajesh Exports Ltd., a renowned name in the gold jewelry industry, has been making waves with its exceptional growth and achievements. With a commitment to quality and craftsmanship, the company has firmly established itself as a leading player in the global market.
Soon Rajesh Exports would be acquiring 100% stake in Keshav Diamonds for Rs. 475 crore. Keshav Diamonds is a leading diamond manufacturer and exporter in India. This acquisition will help RJIL to expand its presence in the diamond industry.
It is all set to to set up a diamond manufacturing park in Karnataka. The park will be spread over an area of 100 acres and will have a capacity to process 10 million carats of diamonds per year.
Rajesh Exports will soon be expanding its presence in the solar energy sector. RJIL is also looking to expand its presence in the jewellery retail market. The company has plans to open new jewellery showrooms in India and abroad.
Credits:- https://www.tradingview.com
With so many expansions inline Rajesh exports is still available at 52 week low and huge volume for buying could be seen in charts since June’23.
The stock could be bought at current price of Rs. 513 and doubled by target of Rs. 1030. C shaped pattern, large volume, 35% quarterly sales growth, Highest ever YoY sales and Net Profits all most confirms the success of the technical chart pattern.
Easy Trip Planners Ltd.
Easy Trip Planners Ltd., a small-cap player in the travel and tourism industry, has been making significant strides, defying market challenges and achieving remarkable milestones. The company recently reported a phenomenal 54% quarter-on-quarter (QoQ) growth in profits, showcasing its resilience and business acumen amid a challenging economic environment.
In addition to its impressive QoQ profit growth, Easy Trip Planners has also reported its highest sales and profits on a year-on-year (YoY) basis. This exceptional performance underscores the company’s ability to capitalize on market opportunities and effectively manage its operations.
Despite the turbulent market conditions, Easy Trip Planners’ stock has demonstrated strong investor interest. As a testament to its potential, the company’s shares are available at a 52-week low, making it an attractive option for investors seeking high-growth opportunities at an affordable entry point.
With acquisition of a majority stake in HolidayIQ, a travel technology company will help ETPL to expand its presence in the online travel market.
With CMP as Rs. 40, ETPL has touched this support thrice. 37% YoY Profit Growth and 54% QoQ Profit growth could push the share prices up.
ETPL stock bought at Rs. 40 could give a potential gain of 20% till its first resistance at Rs. 49 and that of more than 80% if kept till lifetime high at Rs. 72.
Read More:- IRCTC Share Price Target
Use the link to open a Demat account in Zerodha.
Disclaimer- All investments and trading in the stock market involve risk. Any decision to place a trade in the financial markets, including trading in stock should only be made after thorough research. Trading strategies or related information mentioned in the article is for informational purposes only. Use your due diligence before investing. These are just predictions. They may or may not be true. We are not SEBI-registered research analysts.
